PaxMedica (PXMD) News Today $0.0002 0.00 (0.00%) As of 08/25/2025 Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsInsider TradesSEC FilingsShort InterestTrendsBuy This Stock PXMD Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period PaxMedica, Inc. (PXMD) - Yahoo FinanceJuly 11, 2025 | nz.finance.yahoo.comStudy Links Iron Deficiency to Disturbed Sleep Among Autism, ADHD PatientsSeptember 23, 2024 | msn.comBioMedNewsBreaks — PaxMedica Inc. (PXMD) Announces Immediate Exercise of Warrants to Total Approximately $884KSeptember 3, 2024 | msn.comYale Study Unravels Autism, Brain Growth PatternsSeptember 1, 2024 | msn.comPaxMedica, Inc.: PaxMedica Reports First Patient Treated with PAX-101 for Fatal African Sleeping Sickness InfectionAugust 27, 2024 | finanznachrichten.dePaxMedica Files Nasdaq Delisting Appeal Notice and Prepares for Upcoming FDA Meeting on PAX-101May 15, 2024 | globenewswire.comPXMD Stock Earnings: PaxMedica Misses EPS for Q1 2024May 13, 2024 | investorplace.comPaxMedica Provides Company Update and Continues to Advance PAX-101 Regulatory StrategyMay 7, 2024 | markets.businessinsider.comPaxMedica Provides Company Update and Continues to Advance PAX-101 Regulatory StrategyMay 7, 2024 | finance.yahoo.comPaxMedica (NASDAQ: PXMD) Announces PAX-101 Batch Completion for NDA Application to FDAMay 3, 2024 | theglobeandmail.comPaxMedica's CEO and Malawi Health Official Discuss Urgent Medical Crisis in Bell2Bell PodcastApril 26, 2024 | finance.yahoo.comUrgent Action: PaxMedica (NASDAQ: PXMD) Addresses Medical Crisis in MalawiApril 25, 2024 | theglobeandmail.comPaxMedica (NASDAQ: PXMD) Completes Key Step in Preparation of PAX-101 for NDA Submission to FDAApril 25, 2024 | theglobeandmail.comPaxMedica Responds to Emergency Request for IV Suramin and Commits to Provide Immediate Access to PAX-101April 23, 2024 | globenewswire.comPaxMedica, Inc.: PaxMedica Receives Emergency Request for IV Suramin from African Health Ministry for Use in Treating Fatal Sleeping SicknessApril 18, 2024 | finanznachrichten.dePaxMedica, Inc.: PaxMedica Achieves Key Milestone in the Development of PAX-101 And Provides Update on Potential NDA SubmissionApril 12, 2024 | finanznachrichten.deNasdaq Down 300 Points; BlackRock Posts Upbeat EarningsApril 12, 2024 | markets.businessinsider.comPenny Stock PaxMedica's African Sleeping Sickness Candidate Moves Closer To FDA Marketing Application Submission, Stock RalliesApril 12, 2024 | msn.comWhy Is PaxMedica (PXMD) Stock Up 93% Today?April 12, 2024 | investorplace.comWhy Is PaxMedica (PXMD) Stock Up 93% Today?April 12, 2024 | investorplace.comPaxMedica shares soar 125% post-market on drug updateApril 11, 2024 | msn.comPaxMedica Achieves Key Milestone in the Development of PAX-101 And Provides Update on Potential NDA SubmissionApril 11, 2024 | finance.yahoo.comPaxMedica Achieves Key Milestone in the Development of PAX-101 And Provides Update on Potential NDA SubmissionApril 11, 2024 | globenewswire.comPaxMedica (NASDAQ: PXMD) Developing Robust Product Lineup to Address ASD, Associated ConditionsApril 9, 2024 | theglobeandmail.comPaxMedica (NASDAQ: PXMD) on Promising Path to Meet Medical Needs of ASD PatientsMarch 23, 2024 | theglobeandmail.comPaxMedica Updated Company Presentation Highlighting Innovations in Autism Spectrum Disorder TreatmentsMarch 13, 2024 | globenewswire.comPaxMedica Inc Ordinary Shares PXMDMarch 6, 2024 | morningstar.comMPaxMedica Stock (NASDAQ:PXMD), Short Interest ReportFebruary 23, 2024 | benzinga.comPaxMedica (NASDAQ: PXMD) Dedicated to Enhancing Quality of Life for Individuals with ASDJanuary 29, 2024 | theglobeandmail.comIBN Highlights PaxMedica's Video Release on Transformative ASD StudyJanuary 18, 2024 | finance.yahoo.comIBN Highlights PaxMedica’s (NASDAQ: PXMD) Video Release on Transformative ASD StudyJanuary 17, 2024 | theglobeandmail.comPaxMedica on Promising Path to Address Unmet ASD NeedsJanuary 17, 2024 | finance.yahoo.comPaxMedica Files 8-K Following Nasdaq Compliance AchievementDecember 22, 2023 | finance.yahoo.comPaxMedica, Inc. (PXMD) Interactive Stock Chart - Yahoo FinanceDecember 20, 2023 | finance.yahoo.comPaxMedica CEO Howard Weisman Sheds Light on Achievements for ASD Therapy PipelineDecember 19, 2023 | finance.yahoo.comPaxMedica Inc. Covered in H.C. Wainwright & Co. Research ReportDecember 12, 2023 | finance.yahoo.comPaxMedica CEO Featured in Just-Released Fireside Chat VideoDecember 8, 2023 | finance.yahoo.comPaxMedica Releases Fireside Chat Video with CEO Howard WeismanDecember 6, 2023 | finance.yahoo.comHC Wainwright & Co. Initiates Coverage of PaxMedica (PXMD) with Buy RecommendationDecember 5, 2023 | msn.comPaxMedica Stock (NASDAQ:PXMD), Analyst Ratings, Price Targets, PredictionsDecember 4, 2023 | benzinga.comPaxMedica Closes on Public Offering Reaching Estimated $7MDecember 1, 2023 | finance.yahoo.comPaxMedica Announces Closing of $7.0 Million Public OfferingNovember 25, 2023 | finance.yahoo.comPaxMedica, Inc.: PaxMedica Announces Closing of $7.0 Million Public OfferingNovember 22, 2023 | finanznachrichten.dePaxMedica Announces Pricing of $7M Public OfferingNovember 22, 2023 | finance.yahoo.comWhy Is PaxMedica (PXMD) Stock Up 57% Today?November 22, 2023 | investorplace.comPaxMedica News of FDA Type-B Meeting Shared in Audio BroadcastNovember 21, 2023 | finance.yahoo.comWhy Is PaxMedica (PXMD) Stock Down 40% Today?November 20, 2023 | investorplace.comPaxMedica, Inc.: PaxMedica Announces Pricing of $7.0 Million Public OfferingNovember 20, 2023 | finanznachrichten.deCrude Oil Gains Over 2%; PaxMedica Shares PlungeNovember 20, 2023 | markets.businessinsider.comWhy PaxMedica Stock (PXMD) Is Down Nearly 40% TodayNovember 20, 2023 | msn.com Get PaxMedica News Delivered to You Automatically Sign up to receive the latest news and ratings for PXMD and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PXMD Media Mentions By Week PXMD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PXMD News Sentiment▼0.000.70▲Average Medical News Sentiment PXMD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PXMD Articles This Week▼00▲PXMD Articles Average Week Get the Latest News and Ratings for PXMD and Related Stocks Enter your email address to receive the latest news and analysts' ratings for PaxMedica and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies AIMDW News BCTXW News GDTC News ENGNW News FBIOP News GLPG News GOVXW News INDV News INCR News JSPRW News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PXMD) was last updated on 8/26/2025 by MarketBeat.com Staff From Our PartnersThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredFed Decision Warning: How to Protect Your Wealth Before September 30th On September 17th, the Fed faces an impossible choice—and Wall Street insiders are already preparing for the...American Alternative | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PaxMedica, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PaxMedica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access